Valuation: Alpha IVF Group

Market Cap 1.33B 323M 295M 271M 247M 463M 29.95B 487M 3.3B 1.31B 16.36B 1.21B 1.19B 51.34B P/E 2027 *
20.4x
P/E 2028 * 16.2x
Enterprise Value 1.33B 323M 295M 271M 247M 463M 29.95B 487M 3.3B 1.31B 16.36B 1.21B 1.19B 51.34B EV / Sales 2027 *
5.45x
EV / Sales 2028 * 4.5x
Free-Float
22.27%
Yield 2027 *
4%
Yield 2028 * 4.73%
1 day-1.79%
1 week-1.79%
1 month+1.85%
3 months+1.85%
6 months+10.00%
Current year-6.78%
1 week 0.28
Extreme 0.275
0.29
1 month 0.26
Extreme 0.265
0.3
Current year 0.24
Extreme 0.235
0.31
1 year 0.24
Extreme 0.235
0.32
3 years 0.24
Extreme 0.235
0.38
5 years 0.24
Extreme 0.235
0.38
10 years 0.24
Extreme 0.235
0.38
Date Insider Type Main position Quantity % Market Cap. Importance
10/14/26 Others

Chief Executive Officer

150,000 0.0031%
4/30/26 Free

Chief Executive Officer

500,000 0.0103%
3/18/26 Others

Chief Executive Officer

1,555,200,000 32.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-1.79%-1.79%-11.29% - 329M
-2.79%-4.38%+16.90%+42.75% 255B
-3.16%-5.43%-0.82%+4.42% 160B
-2.01%-10.04%-27.74%+28.17% 141B
-2.35%-5.32%-56.54%-22.92% 62.31B
-1.95%-4.95%+21.12%+51.59% 59.73B
-1.96%-1.92%+3.84%-14.15% 53.49B
-2.83%-2.06%+17.45%+49.48% 49.43B
-3.51%-4.30%+16.33%+68.80% 44.87B
+1.26%-11.71%-1.58%+48.97% 42.57B
Average -2.11%-3.79%-2.23%+28.57% 87B
Weighted average by Cap. -2.43%-3.84%-0.31%+27.75%

Financials

2027 *2028 *
Net sales 244M 59.36M 54.07M 49.82M 45.32M 85.02M 5.5B 89.36M 606M 241M 3B 223M 218M 9.42B 296M 71.95M 65.53M 60.38M 54.93M 103M 6.66B 108M 735M 292M 3.64B 270M 264M 11.42B
Net income 65.5M 15.93M 14.51M 13.37M 12.16M 22.81M 1.47B 23.97M 163M 64.66M 806M 59.76M 58.5M 2.53B 83.15M 20.22M 18.41M 16.97M 15.43M 28.96M 1.87B 30.43M 207M 82.08M 1.02B 75.86M 74.26M 3.21B
Net Debt - -
Projected Income Statement - Annual - Alpha IVF Group
Logo Alpha IVF Group
Alpha IVF Group Bhd is a Malaysia-based fertility science, research, and advancement company. The company engages in the provision of assisted reproductive services through its specialist fertility care centers. The company offers access to comprehensive fertility services, technology, and labs across its fertility centers. Its assisted reproductive technologies (ART) refer to a range of medical technologies and treatments complemented with laboratory technologies and procedures to assist individuals or couples in overcoming the challenges of infertility. The company’s assisted reproductive services (ARS) include support services, such as fertility assessment, diagnostics and testing, monitoring, preconception care, and counseling. The medical technologies and treatments of ART are primarily carried out by medical specialists in obstetrics and gynecology, who are also responsible for the prescription of fertility and other related drugs.
Employees
233
Date Price Change Volume
26-11-20 MYR 0.2750 -1.79% 1,130,900
26-11-19 MYR 0.2800 -1.75% 1,370,400
26-11-18 MYR 0.2850 -1.72% 1,372,900
26-11-17 MYR 0.2900 +1.75% 3,420,100
26-11-16 MYR 0.2850 +1.79% 575,200
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - Alpha IVF Group
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.2750MYR
Average target price
0.3300MYR
Spread / Average Target
+20.00%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Alpha IVF Group
  1. Stock Market
  2. Stocks
  3. ALPHA Stock